{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:11:41Z","timestamp":1791223901256,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH grants","award":["MH 0266029"],"award-info":[{"award-number":["MH 0266029"]}]},{"name":"NIH grants","award":["AG027342"],"award-info":[{"award-number":["AG027342"]}]},{"name":"NIH grants","award":["MH51928"],"award-info":[{"award-number":["MH51928"]}]},{"name":"NIH grants","award":["MH6357"],"award-info":[{"award-number":["MH6357"]}]},{"name":"NIH grants","award":["MH037705"],"award-info":[{"award-number":["MH037705"]}]},{"name":"NIH grants","award":["P50 MH066286"],"award-info":[{"award-number":["P50 MH066286"]}]},{"name":"Ortho-McNeil Janssen Scientific Affairs, LLC."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.schres.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T21:08:42Z","timestamp":1311541722000},"page":"35-41","source":"Crossref","is-referenced-by-count":86,"title":["Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory"],"prefix":"10.1016","volume":"132","author":[{"given":"George","family":"Bartzokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan P.","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika P.","family":"Raven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R.","family":"Detore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie R.","family":"Casaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Subotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith H.","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.06.029_bb0005","series-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.schres.2011.06.029_bb0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4088\/JCP.v68n0808","article-title":"Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study","volume":"68","author":"Bai","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0015","first-page":"447","article-title":"Formation, maturation, and disorders of white matter","volume":"13","author":"Barkovich","year":"1992","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.schres.2011.06.029_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0893-133X(02)00364-0","article-title":"Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation","volume":"27","author":"Bartzokis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.06.029_bb0025","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2741\/3881","article-title":"Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments","volume":"17","author":"Bartzokis","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.schres.2011.06.029_bb0030","first-page":"5","article-title":"Biological underpinnings of treatment resistance in schizophrenia: an hypothesis","volume":"37","author":"Bartzokis","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2011.06.029_bb0035","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1176\/appi.ajp.162.6.1229-a","article-title":"Reduced intracortical myelination in schizophrenia","volume":"162","author":"Bartzokis","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0040","first-page":"417","article-title":"Brain Volume: Age-Related Changes","volume":"Vol 2","author":"Bartzokis","year":"2009"},{"key":"10.1016\/j.schres.2011.06.029_bb0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0730-725X(93)90218-3","article-title":"Reliability of in vivo volume measures of hippocampus and other brain structures using MRI","volume":"11","author":"Bartzokis","year":"1993","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.schres.2011.06.029_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","article-title":"Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study","volume":"58","author":"Bartzokis","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0006-3223(02)01835-8","article-title":"Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study","volume":"53","author":"Bartzokis","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.02.011","article-title":"Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia","volume":"93","author":"Bartzokis","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0070","first-page":"185S","article-title":"Abnormal trajectory of intracortical myelination in schizophrenia implicates white matter in treatment response and outcome. Abstract presented at the Society of Biological Psychiatry 66th Annual Meeting, San Francisco, CA.","volume":"69","author":"Bartzokis","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2009.09.009","article-title":"Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia","volume":"115","author":"Cocchi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0085","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.schres.2011.06.029_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2006.09.013","article-title":"Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates","volume":"89","author":"Emsley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0100","series-title":"Die Grosshirnrinde des Menschen in ihren Massen und in ihrem Fasergehalt","author":"Kaes","year":"1907"},{"key":"10.1016\/j.schres.2011.06.029_bb0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.9.1.9","article-title":"Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness","volume":"9","author":"Keith","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.schres.2011.06.029_bb0115","series-title":"Clinical Neurology of Aging","first-page":"3","article-title":"Neuroanatomical and neuropathological changes during aging and dementia","author":"Kemper","year":"1994"},{"key":"10.1016\/j.schres.2011.06.029_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mrm.1910200210","article-title":"Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain","volume":"20","author":"Koenig","year":"1991","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.schres.2011.06.029_bb0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","article-title":"Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys","volume":"63","author":"Konopaske","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0130","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.4088\/JCP.1006e14","article-title":"Neurobiology and the natural history of schizophrenia","volume":"67","author":"Lieberman","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0135","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/schbul\/18.3.387","article-title":"Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress","volume":"18","author":"Nuechterlein","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.06.029_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2004.04.018","article-title":"Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples","volume":"144","author":"Nuechterlein","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2975\/31.4.2008.340.349","article-title":"Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment","volume":"31","author":"Nuechterlein","year":"2008","journal-title":"Psychiatr. Rehabil. J."},{"key":"10.1016\/j.schres.2011.06.029_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: gray matter, white matter, and myelin","volume":"6","author":"O'Brien","year":"1965","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0175","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1185\/03007990903149306","article-title":"Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry","volume":"25","author":"Olivares","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2011.06.029_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.eurpsy.2008.12.002","article-title":"Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)","volume":"24","author":"Olivares","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0185","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-024910-7.50013-0","article-title":"Lipids in the nervous system of different species as a function of age: brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: regulatory mechanisms and membrane structure","volume":"10","author":"Rouser","year":"1972","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0200","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.schres.2011.06.029_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1192\/bjp.bp.109.068577","article-title":"Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology","volume":"196","author":"Saravanan","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine d2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2011.06.029_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-3223(99)00113-4","article-title":"Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure","volume":"46","author":"Selemon","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0225","series-title":"Magnetic Resonance of Myelin, Myelination, and Myelin Disorders","author":"Valk","year":"1989"},{"key":"10.1016\/j.schres.2011.06.029_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00340123","article-title":"MR imaging of the various stages of normal myelination during the first year of life","volume":"31","author":"van der Knaap","year":"1990","journal-title":"Neuroradiology"},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2011.06.029_bb0235","first-page":"1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0240","first-page":"227","article-title":"Brief Psychiatric Rating Scale (BPRS) expanded version: scales, anchor points, and administration manual","volume":"3","author":"Ventura","year":"1993","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2010.02.1068","article-title":"Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain","volume":"119","author":"Wang","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.029_bb0250","first-page":"29","article-title":"Computer-assisted cognitive function assessment in pilots: how and why?","volume":"2","author":"Westerman","year":"2001","journal-title":"Aust. Def. Force Health J."},{"key":"10.1016\/j.schres.2011.06.029_bb0255","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1176\/ajp.2007.164.7.1082","article-title":"Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study","volume":"164","author":"Whitford","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.029_bb0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10198-009-0215-9","article-title":"The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden","volume":"11","author":"Willis","year":"2010","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.schres.2011.06.029_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnbeh.2010.00008","article-title":"Behavioral and neurobiological changes in C57BL\/6 mouse exposed to cuprizone: effects of antipsychotics","volume":"4","author":"Xu","year":"2010","journal-title":"Front. Behav. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411003665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411003665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:40:21Z","timestamp":1686213621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411003665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0920996411003665"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.06.029","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}